563 related articles for article (PubMed ID: 29175000)
1. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
Kelly MP
Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterases in neurodegenerative disorders.
Bollen E; Prickaerts J
IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
[TBL] [Abstract][Full Text] [Related]
3. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
4. Identification and Localization of the Cyclic Nucleotide Phosphodiesterase 10A in Bovine Testis and Mature Spermatozoa.
Goupil S; Maréchal L; El Hajj H; Tremblay MÈ; Richard FJ; Leclerc P
PLoS One; 2016; 11(8):e0161035. PubMed ID: 27548062
[TBL] [Abstract][Full Text] [Related]
5. Alterations in cyclic nucleotide signaling are implicated in healthy aging and age-related pathologies of the brain.
Gorny N; Kelly MP
Vitam Horm; 2021; 115():265-316. PubMed ID: 33706951
[TBL] [Abstract][Full Text] [Related]
6. Adaptation of cAMP signaling system in SH-SY5Y neuroblastoma cells following expression of a constitutively active stimulatory G protein alpha, Q227L Gsalpha.
Jang IS; Juhnn YS
Exp Mol Med; 2001 Mar; 33(1):37-45. PubMed ID: 11322485
[TBL] [Abstract][Full Text] [Related]
7. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
8. Atrial Natriuretic Peptide Affects Stimulus-Secretion Coupling of Pancreatic β-Cells.
Undank S; Kaiser J; Sikimic J; Düfer M; Krippeit-Drews P; Drews G
Diabetes; 2017 Nov; 66(11):2840-2848. PubMed ID: 28864549
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase regulation of alcohol drinking in rodents.
Logrip ML
Alcohol; 2015 Dec; 49(8):795-802. PubMed ID: 26095589
[TBL] [Abstract][Full Text] [Related]
10. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide signalling in kidney fibrosis.
Schinner E; Wetzl V; Schlossmann J
Int J Mol Sci; 2015 Jan; 16(2):2320-51. PubMed ID: 25622251
[TBL] [Abstract][Full Text] [Related]
12. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells.
Tripathi S; Pandey KN
Mol Cell Biochem; 2012 Sep; 368(1-2):47-59. PubMed ID: 22610792
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders.
Khan H; Tiwari C; Grewal AK; Singh TG; Chauhan S; Batiha GE
Inflammopharmacology; 2022 Dec; 30(6):2051-2061. PubMed ID: 36272040
[TBL] [Abstract][Full Text] [Related]
14. Use of a Schizosaccharomyces pombe PKA-repressible reporter to study cGMP metabolising phosphodiesterases.
Demirbas D; Ceyhan O; Wyman AR; Ivey FD; Allain C; Wang L; Sharuk MN; Francis SH; Hoffman CS
Cell Signal; 2011 Mar; 23(3):594-601. PubMed ID: 21118717
[TBL] [Abstract][Full Text] [Related]
15. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
Castro LR; Schittl J; Fischmeister R
Circ Res; 2010 Nov; 107(10):1232-40. PubMed ID: 20847310
[TBL] [Abstract][Full Text] [Related]
16. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
Murthy KS
Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Nucleotides Signaling and Phosphodiesterase Inhibition: Defying Alzheimer's Disease.
Sharma VK; Singh TG; Singh S
Curr Drug Targets; 2020; 21(13):1371-1384. PubMed ID: 32718286
[TBL] [Abstract][Full Text] [Related]
18. cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases.
VerPlank JJS; Tyrkalska SD; Fleming A; Rubinsztein DC; Goldberg AL
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14220-14230. PubMed ID: 32513741
[TBL] [Abstract][Full Text] [Related]
19. Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases.
Xiang Y; Naik S; Zhao L; Shi J; Ke H
Med Res Rev; 2024 Jul; 44(4):1404-1445. PubMed ID: 38279990
[TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
